ORIGINAL RESEARCH
Accepted on 22 May 2025
Chloroquine and Hydroxychloroquine-Related Ocular Adverse Events in SLE Treatment: A Real-World Disproportionality Analysis Based on FDA Adverse Event Reporting System (FAERS) Author
doi 10.3389/fphar.2025.1498814
- 168 views